What It Measures
This test measures the predominant (peak) diameter of LDL cholesterol particles using techniques like ion mobility, gradient gel electrophoresis, or NMR spectroscopy. LDL particles vary in size from small-dense (~200-209 Å) to large-buoyant (~210-233 Å). The peak size reflects whether your LDL profile is predominantly Pattern A (large, buoyant, less harmful) or Pattern B (small, dense, more atherogenic).
LDL Peak Size measures the predominant diameter of low-density lipoprotein particles in the blood, typically reported in angstroms (Å) or nanometers. Smaller, denser LDL particles (Pattern B) are more atherogenic and more easily penetrate arterial walls, while larger, buoyant particles (Pattern A) are associated with lower cardiovascular risk. This biomarker is a key component of advanced lipid testing that goes beyond standard LDL cholesterol levels.
Current Value
What High Means
Larger LDL peak size (Pattern A, above ~210 Å) is generally favorable and associated with lower cardiovascular risk. Large buoyant LDL particles are less likely to penetrate the arterial endothelium, are more resistant to oxidation, and have a shorter half-life in circulation. Higher values indicate a healthier lipid phenotype, often seen with good insulin sensitivity, lower triglycerides, and adequate HDL levels.
Possible Symptoms
Larger LDL peak size is favorable and typically asymptomatic. It reflects good metabolic health. No adverse symptoms are associated with large buoyant LDL particles.
What Low Means
Smaller LDL peak size (Pattern B, below ~210 Å) indicates predominance of small, dense LDL particles, which carry a 2-3x increased risk of coronary heart disease. Small dense LDL is more susceptible to oxidation, penetrates arterial walls more easily, binds more readily to arterial proteoglycans, and has a longer plasma half-life. Low values are associated with insulin resistance, metabolic syndrome, type 2 diabetes, elevated triglycerides, and low HDL cholesterol.
Possible Symptoms
Small dense LDL itself does not cause direct symptoms, but the associated conditions may present as: fatigue, central obesity, skin tags or acanthosis nigricans (insulin resistance signs), elevated blood pressure, and over time the accelerated atherosclerosis can manifest as chest pain (angina), shortness of breath, or cardiovascular events.
Risk Factors
Small LDL peak size is associated with: coronary artery disease, atherosclerosis, metabolic syndrome, insulin resistance, type 2 diabetes, hypertriglyceridemia, low HDL cholesterol, obesity (especially visceral adiposity), familial combined hyperlipidemia, polycystic ovary syndrome (PCOS), non-alcoholic fatty liver disease (NAFLD), and chronic kidney disease.
Actionable Advice
Supplements
- •Omega-3 fatty acids (EPA/DHA)
- •Niacin (vitamin B3)
- •Berberine
- •Citrus bergamot
- •Red yeast rice
- •Plant sterols and stanols
- •Curcumin
- •Fiber supplements (psyllium)
- •Coenzyme Q10
- •Magnesium
Diet & Lifestyle
- •Reduce refined carbohydrates and sugar intake — these are primary drivers of small dense LDL
- •Adopt a Mediterranean or low-glycemic diet rich in healthy fats, vegetables, and lean proteins
- •Exercise regularly — both aerobic and resistance training improve LDL particle size
- •Lose excess body fat, especially visceral/abdominal fat
- •Limit alcohol consumption
- •Prioritize sleep (7-9 hours) — poor sleep worsens insulin resistance and lipid profiles
- •Manage stress through meditation, yoga, or breathing exercises
- •Increase dietary fiber intake to 25-35g per day
- •Include monounsaturated fats (olive oil, avocados, nuts) which shift LDL toward Pattern A
- •Avoid trans fats completely and minimize industrial seed oils
Ask AI
Ask questions about your LDL Peak Size results, trends, and what you can do to optimize.
Historical Trend
Related Biomarkers
Resources & Studies
All Readings
| Date | Value | Change |
|---|---|---|
| 2026-01-28 | 217 Angstrom | 0.0 |
| 2025-08-25 | 217 Angstrom | — |